INNOVATE Corp.

INNOVATE Corp.

VATE
INNOVATE Corp.US flagNew York Stock Exchange
8.05
USD
-0.49
- -
109.82MMarket Cap
INNOVATE Corp.
VATE
(New York Stock Exchange)

Recent

price

8.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
287.59
314.3
216.93
162.8
275.07
419.55
414.53
378.48
442.33
238.31
141.5
155.2
209.75
182.09
103.5
94.27
100.69
Revenue per Share
-19.46
-29.55
19.97
78.76
-8.26
-14.92
-28.04
-11.51
34.82
-6.97
-18.87
-29.58
-5.23
-4.81
-3.35
-4.84
-4.25
Basic EPS, GAAP
10.26
8.7
-5.86
-23.21
-0.04
-18.43
13.33
-5.86
67.51
19.03
4.6
0.37
-3.87
1.04
-0.93
9.12
13.21
Free Cash Flow per Basic Share
- -
- -
39.66
85.41
0.82
2.13
1.12
0.83
0.45
- -
- -
0.37
0.67
0.28
0.11
0.17
0.17
Dividend per Share
-12.59
-38.96
-16.6
-21
-22.18
-29.83
-46.36
-51.23
-12.8
-21.4
-37.23
-53.58
-57.9
-62.36
-48.79
-44.07
-45.15
Book Value per Share
-130.98
-80.77
-39.57
36.01
3.44
-8.46
-25.89
-19.78
-46.88
27.35
61.58
-46.55
-46.68
-58.7
-42.9
-39.1
-40.12
Tangible Book Value per Share
1
1
1
1
2
3
4
4
4
5
5
8
8
8
11
13
13
Basic Weighted Avg Shares
282
412
303
231
547
1,121
1,558
1,634
1,977
1,077
717
1,205
1,637
1,423
1,107
1,246
1,337
Sales/Revenue/Turnover
-2.15
-6.4
-10.26
-15.76
-2.53
0.06
-0.1
-0.07
-2.77
6.99
-3.95
-0.88
0.82
1.86
3.61
2.3
2.64
Operating Margin (%)
68
65
43
24
11
32
29
37
39
8
27
38
42
36
33
30
30
Depreciation Expense
-19
-39
28
112
-14
-36
-94
-47
162
-32
-92
-228
-36
-35
-35
-61
-53
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
1.32
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-6.77
-9.4
9.2
48.38
-2.63
-3.17
-6.07
-2.87
8.2
-2.92
-12.83
-18.88
-2.19
-2.47
-3.13
-4.86
-3.96
Profit Margin (%)
1
-8
9
43
118
1,953
1,969
2,010
4,896
5,584
294
3
121
105
-92
-582
-613
Working Capital
243
246
127
- -
336
370
428
593
710
660
160
615
738
728
544
123
141
LT Debt
83
102
69
54
108
121
70
190
202
455
606
-7
-47
-153
-160
-225
-242
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
-6.16
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
32.29
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
584
594
625
LT Borrowings
97
80
69
LT Finance Leases
42
43
72
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
14
14
14
Market Capitalization
64
60
75

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
421
452
406
Cash, Cash Equivalents & STI
36
112
135
Accounts Receivable, Net
4
4
3
Inventories
18
16
15
Total Current Liabilities
974
1,034
1,020
Payables & Accruals
180
227
204
ST Debt
584
594
625
Deferred Revenue
176
172
157

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
104.57%
150.33%
40.55%
Free Cash Flow
-468.43%
-579.03%
-1,317.17%
Net Income, GAAP
-12.29%
26.91%
75.14%
Sales/Revenue/Turnover
6.71%
16.24%
12.55%
Total Cash Common Dividend
- -
- -
500%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
315
313
242
237
1,107
2025
274
242
347
383
1,246
2026
365
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-2.25
1.58
-1.18
-1.29
-3.35
2025
-1.89
-1.67
-0.71
-0.58
-4.84
2026
-1.29
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.04
0.03
0.02
0.02
0.11
2025
0.02
0.06
0.03
0.05
0.17
2026
0.03
- -
- -
- -
- -
Business
INNOVATE Corp. (NYSE: VATE) operates as a diversified holding company with subsidiaries focused on infrastructure, life sciences, and spectrum segments primarily in the United States; its infrastructure unit through DBM Global Inc. provides fully integrated construction and professional services including design-assist, modularization, fabrication and erection of structural steel, heavy steel plate, trusses and girders, heavy equipment installation, as well as facility maintenance and shutdown services for critical sectors such as infrastructure and energy; the life sciences segment encompasses Pansend Life Sciences developing innovative healthcare technologies to address unmet needs, R2 Technologies offering an FDA-cleared device to soothe, brighten skin and treat visible signs of aging caused by inflammation in the global aesthetic dermatology market, and MediBeacon providing the FDA-approved Transdermal GFR System (TGFR), a point-of-care product for assessing kidney function in patients with normal or impaired renal function targeting a $7 billion market; the spectrum segment operates through HC2 Broadcasting Holdings Inc. and subsidiaries, owning and managing one of the largest broadcast station groups in the U.S. with 256 stations in 106 markets and 2.3 billion MHz POPs of spectrum for over-the-air broadcasting. Founded in 1994 and headquartered at 295 Madison Avenue, 12th Floor, New York, New York, the company, formerly known as HC2 Holdings, Inc. and tracing roots to Primus Telecommunications Group, rebranded to INNOVATE Corp. in September 2021 to emphasize innovative growth businesses across its portfolio serving industrial, healthcare, biotechnology, and media markets. In a significant recent development, INNOVATE Corp. completed a comprehensive debt refinancing in August 2025, restructuring 81.7% of its total outstanding principal debt as of June 30, 2025, by exchanging $328.1 million of existing senior secured notes for new 10.500% Senior Secured Notes due 2027, $48.7 million convertible senior notes for new 9.5% Convertible Senior Secured Notes, amending various credit facilities, and exchanging preferred stock for additional note principal resulting in a $43.0 million CGIC note, while extending maturities on its revolving credit agreement to September 2026, CGIC note to April 2027, Spectrum Notes to September 2026, and R2 Technologies note to August 2026 to enhance financial flexibility.

Company News

APIChatGPT
  • INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

  • INNOVATE Announces Successful Closing of Broadcasting Refinancing and Agrees to Partial Sale of Broadcasting

  • INNOVATE Q1 Loss Narrows Y/Y on Infrastructure, AI Project Demand

  • INNOVATE Q1 Earnings Call Highlights

  • INNOVATE Corp. (VATE) Q1 2026 Earnings Call Prepared Remarks Transcript

  • INNOVATE Corp. Announces First Quarter 2026 Results

  • INNOVATE Corp. to Report First Quarter 2026 Results on May 14th

  • INNOVATE (NYSE:VATE) & Great Elm Group (NASDAQ:GEG) Financial Review

  • Comparing Livento Group (OTCMKTS:NUGN) and INNOVATE (NYSE:VATE)

  • INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

  • MediBeacon® Transdermal GFR Monitor and Reusable Sensor Receive CE Mark Under European Medical Device Regulation

  • INNOVATE Corp. (VATE) Q4 2025 Earnings Call Prepared Remarks Transcript

  • INNOVATE Corp. Announces Fourth Quarter and Full Year 2025 Results

  • INNOVATE Corp. to Report Fourth Quarter and Full Year 2025 Results on March 26th

  • Reviewing INNOVATE (NYSE:VATE) and La Rosa (NASDAQ:LRHC)

  • Analyzing Barloworld (OTCMKTS:BRRAY) and INNOVATE (NYSE:VATE)

  • INNOVATE (NYSE:VATE) Shares Down 0.8% – Here’s Why

  • Transdermal GFR Article Recognized as One of Five 2025 Editors' Choice Articles by Journal of the American Society of Nephrology (JASN)

  • INNOVATE's Portfolio Company DBM Global to Pay Cash Dividend

  • Contrasting INNOVATE (NYSE:VATE) & Carlisle Companies (NYSE:CSL)